Bishop Daniel E. Thomas Supports Bill to End FDA Approval of Chemical Abortion Pills

| 04/2/2026

By: The Good Newsroom

The bishop emphasized the USCCB’s opposition to the chemical abortion drug not only for its purpose of terminating life, but also that the abortion pill represents an isolating and harmful response to women in need

Signage is seen outside of the Food and Drug Administration headquarters in White Oak, Maryland, August 29, 2020.
Signage is seen outside of the Food and Drug Administration headquarters in White Oak, Maryland, August 29, 2020. (OSV News photo/Andrew Kelly, Reuters)

WASHINGTON – “The abortion pill represents an isolating and harmful response to women in need,” said Bishop Daniel E. Thomas, chairman of the U.S. Conference of Catholic Bishops’ Committee on Pro-Life Activities. On Wednesday, Bishop Thomas wrote a letter to Congress in support of the “Safeguarding Women from Chemical Abortion Act,” which was recently introduced by Senator Josh Hawley and Representative Diana Harshbarger. The bill (S.4066/H.R.7902) would withdraw the U.S. Food and Drug Administration’s (FDA) approval of mifepristone for abortions.

In his letter, Bishop Thomas stated that the bill would likely save lives by curtailing the incidence of chemical abortion itself as well as its associated risks to the mothers. He emphasized the bishops’ opposition to the chemical abortion drug not only for its purpose of terminating life, but also that the abortion pill represents an isolating and harmful response to women in need.

Read Bishop Thomas’ letter here.

Durante este mes se celebrarán misas en honor a las patronas de Cuba, Venezuela, Ecuador y la República Dominicana.

By:

Armando Machado

| 06/17/2026

04:06
On Tuesday, June 16, the 17th annual Catholic Charities gala took place at the American Museum of Natural History in Manhattan, welcoming more than 850 supporters.

By:

Fernanda Pierorazio

| 06/17/2026

New report finds government restrictions on religion at a 16-year high, while social hostilities surged in 2023 amid harassment of minorities and fallout from the Israel-Hamas war.

By:

OSV News

| 06/17/2026